U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H42N.Br
Molecular Weight 412.49
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MYRISTALKONIUM BROMIDE

SMILES

[Br-].CCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1

InChI

InChIKey=CSNHNGDROQRZKT-UHFFFAOYSA-M
InChI=1S/C23H42N.BrH/c1-4-5-6-7-8-9-10-11-12-13-14-18-21-24(2,3)22-23-19-16-15-17-20-23;/h15-17,19-20H,4-14,18,21-22H2,1-3H3;1H/q+1;/p-1

HIDE SMILES / InChI

Molecular Formula C23H42N
Molecular Weight 332.5863
Charge 1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://drugs.medelement.com/drug/%D0%A4%D0%B0%D1%80%D0%BC%D0%B0%D1%82%D0%B5%D0%BA%D1%81-20%D0%BC%D0%B3-%D0%B8%D0%BD%D1%81%D1%82%D1%80%D1%83%D0%BA%D1%86%D0%B8%D1%8F?instruction_lang=RU | http://xn-----8kceunaflgjrqyoqfbei8dxl.xn--p1ai/%D0%BC%D0%B8%D1%80%D0%B8%D1%81%D1%82%D0%B0%D0%BB%D0%BA%D0%BE%D0%BD%D0%B8%D1%8F_%D1%85%D0%BB%D0%BE%D1%80%D0%B8%D0%B4

Myristalkonium is used as spermicide in vaginal contraceptives. It has antiseptic properties also. Breastfeeding women might use it because it does not pass into maternal milk. Absorbed only on the surface of the walls of the vagina and then return to normal physiological droppings or eliminates simple washing with water. Adverse effects are: burning, itch, contact dermatitis. Any drug, introduced into the vagina, can inactivate the local spermicidal action of Myristalkonium.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
Pharmatex

Approved Use

Myristalkonium is used as spermicide.
PubMed

PubMed

TitleDatePubMed
Enhancement of the luminescence efficiency of europium(III) tris(β-diketonato) complex in organic media by quaternary ammonium salts with anionic ligands.
2011
Biosorption of tetradecyl benzyl dimethyl ammonium chloride on activated sludge: kinetic, thermodynamic and reaction mechanisms.
2011 Feb
Patents

Sample Use Guides

Capsule/suppository/tablet injected deep into the vagina at the latest 5-10 minutes before but not longer than 3 hours before sexual intercour.
Route of Administration: Vaginal
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 04:53:35 GMT 2023
Edited
by admin
on Sat Dec 16 04:53:35 GMT 2023
Record UNII
994565XU0T
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MYRISTALKONIUM BROMIDE
Common Name English
TETRADECYLBENZYLDIMETHYLAMMONIUM BROMIDE
Systematic Name English
AMMONIUM, BENZYLDIMETHYLTETRADECYL-, BROMIDE
Systematic Name English
BENZYLDIMETHYLTETRADECYLAMMONIUM BROMIDE
Systematic Name English
BENZENEMETHANAMINIUM, N,N-DIMETHYL-N-TETRADECYL-, BROMIDE
Systematic Name English
BENZENEMETHANAMINIUM, N,N-DIMETHYL-N-TETRADECYL-, BROMIDE (1:1)
Systematic Name English
MIRISTALKONIUM BROMIDE
Common Name English
Code System Code Type Description
PUBCHEM
9866364
Created by admin on Sat Dec 16 04:53:35 GMT 2023 , Edited by admin on Sat Dec 16 04:53:35 GMT 2023
PRIMARY
FDA UNII
994565XU0T
Created by admin on Sat Dec 16 04:53:35 GMT 2023 , Edited by admin on Sat Dec 16 04:53:35 GMT 2023
PRIMARY
EPA CompTox
DTXSID10172080
Created by admin on Sat Dec 16 04:53:35 GMT 2023 , Edited by admin on Sat Dec 16 04:53:35 GMT 2023
PRIMARY
CAS
18773-88-1
Created by admin on Sat Dec 16 04:53:35 GMT 2023 , Edited by admin on Sat Dec 16 04:53:35 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY